PMCC PMCC

Search tips
Search criteria

Advanced
Results 1-14 (14)
 

Clipboard (0)
None
Journals
more »
Authors
more »
Year of Publication
Document Types
1.  Licensing the future: report on BioMed Central’s public consultation on open data in peer-reviewed journals 
BMC Research Notes  2013;6:318.
We report the outcomes of BioMed Central’s public consultation on implementing open data-compliant licensing in peer-reviewed open access journals. Respondents (42) to the 2012 consultation were six to one in favor (29 in support; 5 against; 8 abstentions) of changing our authors’ default open access copyright license agreement, to introduce the Creative Commons CC0 public domain waiver for data published in BioMed Central’s journals. We summarize the different questions we received in response to the consultation and our responses to them – matters such as citation, plagiarism, patient privacy, and commercial use were raised. In light of the support for open data in our journals we outline our plans to implement, in September 2013, a combined Creative Commons Attribution license for published articles (papers) and Creative Commons CC0 waiver for published data.
doi:10.1186/1756-0500-6-318
PMCID: PMC3751723  PMID: 23962139
2.  Open by default: a proposed copyright license and waiver agreement for open access research and data in peer-reviewed journals 
BMC Research Notes  2012;5:494.
Copyright and licensing of scientific data, internationally, are complex and present legal barriers to data sharing, integration and reuse, and therefore restrict the most efficient transfer and discovery of scientific knowledge. Much data are included within scientific journal articles, their published tables, additional files (supplementary material) and reference lists. However, these data are usually published under licenses which are not appropriate for data. Creative Commons CC0 is an appropriate and increasingly accepted method for dedicating data to the public domain, to enable data reuse with the minimum of restrictions. BioMed Central is committed to working towards implementation of open data-compliant licensing in its publications. Here we detail a protocol for implementing a combined Creative Commons Attribution license (for copyrightable material) and Creative Commons CC0 waiver (for data) agreement for content published in peer-reviewed open access journals. We explain the differences between legal requirements for attribution in copyright, and cultural requirements in scholarship for giving individuals credit for their work through citation. We argue that publishing data in scientific journals under CC0 will have numerous benefits for individuals and society, and yet will have minimal implications for authors and minimal impact on current publishing and research workflows. We provide practical examples and definitions of data types, such as XML and tabular data, and specific secondary use cases for published data, including text mining, reproducible research, and open bibliography. We believe this proposed change to the current copyright and licensing structure in science publishing will help clarify what users – people and machines – of the published literature can do, legally, with journal articles and make research using the published literature more efficient. We further believe this model could be adopted across multiple publishers, and invite comment on this article from all stakeholders in scientific research.
doi:10.1186/1756-0500-5-494
PMCID: PMC3465200  PMID: 22958225
3.  A call for BMC Research Notes contributions promoting best practice in data standardization, sharing and publication 
BMC Research Notes  2010;3:235.
BMC Research Notes aims to ensure that data files underlying published articles are made available in standard, reusable formats, and the journal is calling for contributions from the scientific community to achieve this goal. Educational Data Notes included in this special series should describe a domain-specific data standard and provide an example data set with the article, or a link to data that are permanently hosted elsewhere. The contributions should also provide some evidence of the data standard's application and preparation guidance that could be used by others wishing to conduct similar experiments. The journal is also keen to receive contributions on broader aspects of scientific data sharing, archiving, and open data.
doi:10.1186/1756-0500-3-235
PMCID: PMC2940773  PMID: 20813027
4.  The Ideal Stimulation Protocol: Is There One? 
doi:10.1007/s13224-015-0723-8
PMCID: PMC4666208  PMID: 26663992
6.  The CQC inspections: what they mean for general practice 
doi:10.3399/bjgp15X683845
PMCID: PMC4337279  PMID: 25733412
7.  Editorial 
Brain  2015;138(3):505-506.
doi:10.1093/brain/awv019
PMCID: PMC4408441  PMID: 25713399
8.  Life as a new investigator 
doi:10.1186/s40697-015-0083-4
PMCID: PMC4666171  PMID: 26629353
9.  Surrogate clinical endpoints to predict overall survival in non-small cell lung cancer trials—are we in a new era? 
Surrogate endpoints for clinical trials in oncology offer an alternative metric for measuring clinical benefit, allowing for shorter trial duration, smaller patient cohorts, and single arm design. The correlation of surrogate endpoints with overall survival (OS) in therapeutic studies is a central consideration to their validity. The Food and Drug Administration (FDA) recently published an analysis of fourteen clinical trials in advanced non-small cell lung cancer (NSCLC), and discovered a strong association between response rate and progression free survival. Furthermore, a correlation between response rate and OS is demonstrated when analyzing the experimental treatment arm separately, minimizing bias from patient crossover. We also highlight multiple, important considerations when using response as an endpoint in clinical trials involving NSCLC patients.
doi:10.3978/j.issn.2218-6751.2015.05.03
PMCID: PMC4700223  PMID: 26798592
Lung cancer; surrogate; endpoint; response; survival
10.  Recommendations for resistance training in patients with fibromyalgia 
It may seem counter-intuitive to purposely stress muscle in patients who have muscle pain. However, a growing body of evidence challenges the assumption that resistance (strength) training worsens muscle pain in people with fibromyalgia (FM). In fact, the latest evidence indicates that when resistance training is tailored to individual needs, people with FM can obtain worthwhile improvements in FM severity. Clinicians need a deeper understanding of how resistance training helps people with FM, so as to prescribe more specific, personalized resistance training to their patients.
doi:10.1186/s13075-015-0782-3
PMCID: PMC4574136  PMID: 26377808
11.  Bioassays for TSH Receptor Antibodies: Quo Vadis? 
European Thyroid Journal  2015;4(1):3-5.
doi:10.1159/000375445
PMCID: PMC4404890  PMID: 25960955
13.  Research! Research! Research! What are Thou? 
doi:10.13107/jocr.2250-0685.104
PMCID: PMC4719246  PMID: 27298907
14.  Editorial 
PMCID: PMC4968182  PMID: 27507926

Results 1-14 (14)